Higher adiposity in infancy associated with recurrent wheeze in a prospective cohort of children
- PMID: 18466784
- PMCID: PMC3253368
- DOI: 10.1016/j.jaci.2008.03.021
Higher adiposity in infancy associated with recurrent wheeze in a prospective cohort of children
Abstract
Background: Few prospective data link early childhood adiposity with asthma-related symptoms.
Objective: We sought to examine the associations of weight-for-length (WFL) at age 6 months with incidence of wheezing by age 3 years.
Methods: We studied 932 children in a prospective cohort of children. The main outcome was recurrent wheezing, which was defined as parents' report of wheezing between 2 and 3 years of age plus wheezing in either year 1 or 2 of life. Secondary outcomes included any wheezing from 6 months to 3 years and current asthma. We used multiple logistic regression to examine associations of 6-month WFL z scores with these outcomes.
Results: At 6 months, the infants' mean WFL z score was 0.68 (SD, 0.94; range -2.96 to 3.24). By age 3 years, 14% of children had recurrent wheezing. After adjustment for a variety of potential confounders, we found that each 1-unit increment in 6-month WFL z score was associated with greater odds of recurrent wheezing (odds ratio [OR], 1.46; 95% CI, 1.11-1.91) and any wheezing (OR, 1.23; 95% CI, 1.03-1.48). We observed a weaker association between 6-month WFL z score and current asthma (OR, 1.22; 95% CI, 0.94-1.59).
Conclusion: Infants with higher WFL z scores at 6 months of age had a greater risk of recurrent wheezing by age 3 years. It is unclear whether the relationship of infant adiposity and early-life wheeze extends to allergic asthma or wheeze that can persist into later childhood. Our findings suggest that early interventions to prevent excess infant adiposity might help reduce children's risk of asthma-related symptoms.
Conflict of interest statement
Disclosure of potential conflict of interest: S. T. Weiss has consulting arrangements with Genentech and GlaxoSmithKline, has received research support from GlaxoSmith-Kline, and is on the advisory board for Genentech. The rest of the authors have declared that they have no conflict of interest.
References
-
- Merrill CT, Elixhauser A. Rockville (MD): Agency for Healthcare Research and Quality; 2005. Hospitalization in the United States, 2002: HCUP Fact Book no 6. Available at: http://www.ahrq.gov/data/hcup/factbk6/
-
- Moonie SA, Sterling DA, Figgs L, Castro M. Asthma status and severity affects missed school days. J Sch Health. 2006;76:18–24. - PubMed
-
- Sherman CB, Tosteson TD, Tager IB, Speizer FE, Weiss ST. Early childhood predictors of asthma. Am J Epidemiol. 1990;132:83–95. - PubMed
-
- Yunginger JW, Reed CE, O’Connell EJ, Melton LJ, III, O’Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma: incidence rates, 1964–1983. Am Rev Respir Dis. 1992;146:888–894. - PubMed
-
- Ogden CL, Troiano RP, Briefel RR, Kuczmarski RJ, Flegal KM, Johnson CL. Prevalence of overweight among preschool children in the United States, 1971 through 1994. Pediatrics. 1997;99:e1. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources